Immune inhibitors like PD-1, BTLA and CTLA-4 were significantly highly expressed in metastatic tumors with reduced neoantigens, which further supported that reduction of neoantigens was associated with functional deficiency of immune cells (Figure 3F). The gene discussed is BTLA; the disease is metastatic neoplasm.